BIT's 16th Annual World Congress of
Drug Discovery Science & Technology - Jinan 2018
Theme: Focusing on Biomedical Frontiers, Driving Industrial Innovative Development
Time: November 6-8, 2018
Place: Jinan, China
Preliminary Scientific Program
Session times on those days will not be finalized until the overall program schedule is completed.
Program Sessions (Please click each Forum for detailed program information) |
Stream 5: Translational Medicine, Clinical Trials, Drug Administrative Approval, and Market Development |
|
Chair |
Dr. King C. Lee, Professor, Quinnipiac University, USA |
13:30-13:35 |
Chair's Introduction |
13:35-13:55 |
Title: Challenges and Solutions in Clinical Research |
13:55-14:15 |
Title: Approval of Pharma/Biologic Products in US-What Can a Small Startup Chinese Company Do? |
14:15-14:35 |
Title: Strategies for Obtaining Patents on Biomedical Inventions in the United States with a View to Successfully Withstand Critical Scrutiny by the Federal Courts and the Patent Trial and Appeal Board of the USPTO for their Validity and Enforceability |
14:35-14:55 |
Title: Translational Medicine: Use of Human Disease Models in Early Clinical Development |
14:55-15:15 | Title: GXP (GCP/ GLP/ GMP) Challenges in Drug Development Dr. Frank Cheng, CEO and Senior Consultant, NovoScience Consulting Hong Kong, China |
Ji'nan Branch of China Council for The Promotion of International Trade
University of South Australia
School of Biological Engineering, Qilu University of Technology
![]() Jinan Innovation Zone Life Science Development City |
![]() |
BIT Group Global Ltd. |
Amgen, Inc.
Arrowhead Pharmaceuticals Inc.
Eisai Co., Ltd.
ChemDiv, Inc.
University of Queensland
Comenius University
Fountain Medical Development Ltd.,
McGill University
Pharmaron Inc.
Pfizer Inc.
Florida State University
Shanghai Jiaotong University School of Medicine
Leydig, Voit & Mayer, Ltd.
University of Pittsburgh
F. Hoffmann-La Roche
Tactical Therapeutics, Inc.
Leadscope Inc.
AbbVie Deutschland GmbH & Co. KG
Merck KGaA
Genentech, Inc.
Sanofi
Hamamatsu Photonics K.K.
University of Arizona
ChemDiv, Inc
AbMax Biotechnology Inc.
University Hospital Brno and Medical Faculty of Masaryk University
PSMMC, Riyadh
Boehringer Ingelheim Pharma GmbH & Co. KG
Global PKPD & Pharmacometrics, Eli Lilly and Company
Beijing Institute of Pharmacology and Toxicology
Auckland UniVersity
Cyclenium Pharma Inc.
Helmholtz Centre for Infection Research
University of Arizona
Medlab Clinical Pty Ltd.
National Institute of Biological Sciences, Beijing
Quinnipiac University/King Lee PhD, LCC
Novartis Institue of Biomedical Research
IriSys, LLC,
Private Clinic of Dermatovenerology Svidník
Saarland University
Cardiff University
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609-826, Fax: 0086-411-84796897
Copyright © 2017-2018 BIT Congress Inc.